期刊文献+

^18FDG SUV值对直肠癌预后预测价值的探讨

Significance of standard uptake value of ^(18)FDG PET/CT in predicting prognosis of rectal cancer
原文传递
导出
摘要 目的:探讨直肠癌术前18FDGPET/CT标准摄取值(SUV)及临床病理特征与预后的关系。方法:应用单因素和多因素分析方法,对进行根治性切除术前行18FDGPET/CT检查的44例直肠癌患者的PET/CTSUV值及临床病理特征与5年生存率的相关性进行研究。结果:44例直肠癌患者5年总生存率为61.3%。单因素分析显示,患者的年龄、肿瘤浸润深度、有无淋巴结转移、术前18FDGPET/CTSUV值及血清癌胚抗原是影响患者预后的主要因素。应用Cox比例危险回归模型分析显示,肿瘤的浸润深度、淋巴结转移和18FDGSUV值是影响直肠癌患者的独立预后因素。结论:18FDGSUV是影响直肠癌患者预后的重要指标之一,可为临床判断直肠癌患者预后提供有效工具。 OBJECTIVE:To investigate the correlations of 18fluorodeoxylucose PET/CT standard uptake value before surgery and clinicopathologic features with the prognosis of rectal cancer.METHODS:The 18fluorodeoxylucose PET/CT standard uptake value before surgery,clinicopathologic features and 5-year over survival in 44 patients with rectal cancer were univariately and multivariately analyzed.RESULTS:The overall 5-year survival rate of the patients with rectal cancer after surgery and chemo-radiotherapy was 61.3%.The factors of ages,depth of infiltration,lymph nodal metastasis,carcinoembryonic antigen(CEA)and 18FDG PET/CT standard uptake value before surgery influenced the overall survival by univariate analysis.The factors of depth of infiltration,lymph nodal metastasis and 18FDG PET/CT standard uptake value were available independent prognostic factors by multivariate analysis(cox).CONCLUSION:FDG SUV,as a most important available independent prognostic factor,is able to assess the postoperative survival of rectal cancer patients.
出处 《中华肿瘤防治杂志》 CAS 2009年第20期1594-1596,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 正电子发射型计算机断层显像 ^18氟脱氧葡萄糖 直肠肿瘤 标准摄取值 预后 positron emission tomography 18fluorodeoxylucose rectal neoplasms standard uptake value prognosis
  • 相关文献

参考文献10

  • 1Guillem J G, Moore H G, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation:a means for determining long term outcomes of rectal cancer[J]. J Am Coll Surg,2004,199(1):1-7.
  • 2Oku S, Nakagawa K, Momose T, et al. FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer[J]. Ann Nucl Med,2002,16(6):409-416.
  • 3Mochiki E, Kuwano H, Katoh H, et al. Evaluation of ^18F-2-de oxy-2-fluoro D-glucose positron emission tomography for gastric cancer[J]. World J Surg, 2004,28(3) :247-253.
  • 4闫先侠,王传新,牛爱军,王燕,陈英剑.结直肠癌及淋巴结组织CEA mRNA表达的实时荧光定量检测[J].中华肿瘤防治杂志,2008,15(16):1255-1258. 被引量:4
  • 5Tanaka K, Noura S, Ohue M, et al. Doubling time of carcino embryonic antigen is a significant prognostic factor after the sur gical resection of locally recurrent rectal cancer[J]. Dig Surg 2008,25(4):319-324.
  • 6Tomisaki S, Ohno S, Ichiyoshi Y, et al. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer[J]. Cancer, 1996,77(8 Suppl):1722-1728.
  • 7Secco G B, Fardelli R, Gianquinto D, et al. Factors influencing incidence and extension of metachronous liver metastases of colorectal adenocarcinoma. A multivariate analysis[J]. Hapatogastroenterology, 1997,44(16) :1057-1062.
  • 8Trabelsi O, Hassair M, Haouet K, et al. Colon cancer. Study of 153 cases and comparison with a series of 140 historic cases[J]. Tunis Med,1999,77(12)1621-630.
  • 9Colquhoun P H, Wexner S D. Surgical management of colon cancer [J]. Curr Gastroenterol Rep, 2002,4(5) :414-419.
  • 10吕洋,赵坡.大肠癌383例的临床病理及预后分析[J].中华肿瘤防治杂志,2007,14(8):613-616. 被引量:17

二级参考文献17

  • 1郝立强,孟荣贵,傅传刚,张卫,崔龙,戴建新.定量检测大肠癌及大肠良性疾病癌胚抗原信使核糖核酸的研究[J].中华实验外科杂志,2004,21(7):784-786. 被引量:4
  • 2吕其安,张明伟,李敏,张林祥,解丽梅,吴晓玲,张仁亚.Survivin基因和癌胚抗原在大肠癌组织中的表达及其预后关系的研究[J].中华肿瘤防治杂志,2007,14(6):440-442. 被引量:3
  • 3Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chainreaction[J]. Cancer Res, 1995, 55( 15):3417-3420.
  • 4Karsai A, Muller S, Platz S, et al. Evaluation of a homemade SYBR green Ⅰ reaction mixture for real-time PCR quantification of gene expression[J]. Biotechniques, 2002, 32 (4):790-796.
  • 5Remedios C, Amparo E, Carlos V, et al. Quantitative Real time reverse transcription PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type Ⅰ, and tissue metalloproteinase inhibitor type Ⅰ gene expressions in primary breast cancer[J]. Clinical Chemistry, 2002, 48(8):1288-1295.
  • 6Luketich J D, Kassis E S, Shriver S P, et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer[J]. Ann Thorac Surg, 19.98, 66(5) : 1715-1718.
  • 7Godfrey T E, Raja S, Finkelstein S D, et al. Prognostic value of quantitative reverse transcription polymerase chain reaction in lymph node-negative esophageal cancer patinets clin[J]. Cancer Res, 2001, 61(17):4041-4048.
  • 8Ponz de Leon M,Sant M,Micheli A,et al.Clinical and pathologic prognostic indicators in colorectal cancer:a population based study[J].Cancer,1992,69(3):625-635.
  • 9Deans G T,Patterson C C,Parks T G,et al.Colorectal carcinoma:importance of clinical and pathologic factors in survival[J].Ann R Coll Surg Engl,1994,76(1):59-64.
  • 10Park Y J,Park K J,Park J G,et al.Pathologic factors in 2230 Korean colorectal cancer patients:analysis of consecutively operated cases[J].World J Surg,1999,23(7):721-726.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部